THE EFFECTS OF ANTICONVULSANT DRUGS ON VITAMIN-D3-ACTIVATING CYTOCHROME-P-450-LINKED MONOOXYGENASE SYSTEMS

被引:23
作者
TOMITA, S [1 ]
OHNISHI, J [1 ]
NAKANO, M [1 ]
ICHIKAWA, Y [1 ]
机构
[1] UNIV HOSP KAGAWA,KAGAWA MED SCH,FAC MED,DEPT BIOCHEM,DIV PHARM,MIKI CHO,KAGAWA 76107,JAPAN
关键词
D O I
10.1016/0960-0760(91)90241-V
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of two anticonvulsant drugs, phenytoin and sodium valproate, on the bioactivation of vitamin D3 have been studied with respect to the microsomal and mitochondrial cytochrome P-450-linked monooxygenase systems that contribute to 25-hydroxylation of vitamin D3 in rabbit liver, and the mitochondrial cytochrome P-450-linked monooxygenase system that catalyzes 1-alpha-hydroxylation of 25-hydroxyvitamin D3 in rabbit kidney. These anticonvulsant drugs were found to inhibit the 25-hydroxylase activity on vitamin D3 in liver microsomes and mitochondria, respectively, but not to inhibit the 1-alpha-hydroxylation of 25-hydroxyvitamin D3, even over a wide concentration range. Moreover, the activities of the components of the cytochrome P-450-linked monooxygenase systems: NADPH-cytochrome P-450 reductase, NADPH-ferredoxin reductase and ferredoxin, were never inhibited by these drugs. It is possible that the inhibition of bioactivation of vitamin D3 by these anticonvulsant drugs causes rickets and osteomalacia, and the site of inhibition is expected to be the cytochrome P-450 mediated reactions in liver mitochondria.
引用
收藏
页码:479 / 485
页数:7
相关论文
共 26 条
[1]   SUBCELLULAR LOCATION OF RAT-LIVER CALCIFEROL-25-HYDROXYLASE [J].
BHATTACHARYYA, MH ;
DELUCA, HF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1974, 160 (01) :58-62
[2]   THE VITAMIN-D STORY - A COLLABORATIVE EFFORT OF BASIC SCIENCE AND CLINICAL MEDICINE [J].
DELUCA, HF .
FASEB JOURNAL, 1988, 2 (03) :224-236
[3]  
ERNST M, 1990, J BONE MINER RES, V5, pS273
[4]   UNIQUE BIOSYNTHESIS BY KIDNEY OF A BIOLOGICALLY ACTIVE VITAMIN-D METABOLITE [J].
FRASER, DR ;
KODICEK, E .
NATURE, 1970, 228 (5273) :764-&
[5]  
HAHN TJ, 1975, NEW ENGL J MED, V292, P550, DOI 10.1056/NEJM197503132921102
[6]   PROPERTIES OF CRYSTALLINE REDUCED NICOTINAMIDE ADENINE-DINUCLEOTIDE PHOSPHATE-ADRENODOXIN REDUCTASE FROM BOVINE ADRENOCORTICAL MITOCHONDRIA .1. PHYSICOCHEMICAL PROPERTIES OF HOLO-NADPH-ADRENODOXIN AND APO-NADPH-ADRENODOXIN REDUCTASE AND INTERACTION BETWEEN NON-HEME IRON PROTEINS AND REDUCTASE [J].
HIWATASHI, A ;
ICHIKAWA, Y ;
MARUYA, N ;
YAMANO, T ;
AKI, K .
BIOCHEMISTRY, 1976, 15 (14) :3082-3090
[7]   HETEROGENEITY OF ADRENOCORTICAL FERREDOXIN [J].
HIWATASHI, A ;
SAKIHAMA, N ;
SHIN, M ;
ICHIKAWA, Y .
FEBS LETTERS, 1986, 209 (02) :311-315
[8]   IN VITRO PRODUCTION OF 25-HYDROXYCHOLECALCIFEROL [J].
HORSTING, M ;
DELUCA, HF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1969, 36 (02) :251-&
[9]   ALTERED CALCIUM METABOLISM IN EPILEPTIC CHILDREN ON ANTICONVULSANTS [J].
HUNTER, J ;
MAXWELL, JD ;
STEWART, DA ;
PARSONS, V ;
WILLIAMS, R .
BMJ-BRITISH MEDICAL JOURNAL, 1971, 4 (5781) :202-+
[10]   TISSUE AND SUBCELLULAR DISTRIBUTIONS OF CHOLECALCIFEROL 25-HYDROXYLASE - CYTOCHROME-P-450D25-LINKED MONOOXYGENASE SYSTEM [J].
ICHIKAWA, Y ;
HIWATASHI, A ;
NISHII, Y .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1983, 75 (03) :479-488